abstract |
The novel vaccine composition of the present invention comprises hepatitis B antigen formulated with aluminum phosphate. The vaccine composition of the present invention may further contain inactivated hepatitis A virus, aluminum hydroxide and formol. Mixed hepatitis A and B vaccine formulations may optionally be administered to human subjects in a two dose regimen. Suitable formulations are illustrated. |